PERSPECTA

News from every angle

← Back to headlines

Carlsmed raises FY 2026 revenue outlook to $72M-$77M as CMS proposes new MS-DRGs for aprevo lumbar

PostShare

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.

seeking-alphaglg1h ago

Carlsmed raises FY 2026 revenue outlook to $72M-$77M as CMS proposes new MS-DRGs for aprevo lumbar

Read full article →

Related Stories

Hantavirus: The rare virus infecting passengers on luxury cruise ship Hondius

just now

Philippines to Procure 32,000 Female Pigs for ASF Recovery

just now

Understanding Fibromyalgia: A Chronic Pain Condition

just now

New country legend Dolly Parton's news worries fans

7m ago